Level Biotechnology Inc. (TPEX:3118)

Taiwan · Delayed Price · Currency is TWD

31.75

+0.10 (0.32%)

Aug 4, 2026, 1:30 PM CST

-1.40% (1Y)

Market Cap	1.03B -1.7%
Revenue (ttm)	718.58M -1.6%
Net Income	77.15M +17.8%
EPS	2.36 +17.4%
Shares Out	32.45M
PE Ratio	13.41
Forward PE	n/a
Dividend	2.20 (6.95%)
Ex-Dividend Date	Jun 10, 2026

Volume	1,103
Open	31.75
Previous Close	31.65
Day's Range	31.75 - 31.75
52-Week Range	30.85 - 34.70
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Level Biotechnology

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. The company markets and distributes biomedical precision equipment. It also provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. In addition, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. The company was founded in 1989 and is headquartered in New Taipei Ci... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1989

Employees 128

Stock Exchange Taipei Exchange

Ticker Symbol 3118

Full Company Profile

Financial Performance

In 2025, Level Biotechnology's revenue was 736.59 million, an increase of 0.72% compared to the previous year's 731.35 million. Earnings were 79.70 million, an increase of 22.97%.

Financial Statements